© 2020 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
I’ve got a proper measuring tool—and a good reason to use it.
In today’s society, it appears it is just fine to absolve yourself of any accountability. Instead, ask your local politicians to draft up a la...
A vaginal gel with the HIV drug tenofovir, which was created to reduce the odds of HIV transmission, has proved surprisingly effective against...
People taking the antiretroviral (ARV) drug tenofovir (found in Viread, Truvada and Atripla) as part of their HIV treatment regimen had no bet...
An experimental vaccine failed to protect HIV-negative women from developing genital herpes, according to a statement by the National Institut...
Almost one in every two African-American women ages 14 to 49 has genital herpes, as does two out of every five blacks in that age group.
Acyclovir doesn’t prevent HIV-positive people from transmitting the virus to their uninfected partners, but it does appear to slow HIV disease...
Researchers at XVII IAC in Mexico City affirmed long-term treatment of genital herpes with drug acyclovir does not reduce HIV transmission.
Approximately 26 percent of New Yorkers are infected with the Herpes Simplex Virus-2, the virus that causes genital herpes
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
